EP1499196A1 - Diabetic, bran-free flour for the production of baking industry products, especially bread, pastries and cakes - Google Patents
Diabetic, bran-free flour for the production of baking industry products, especially bread, pastries and cakesInfo
- Publication number
- EP1499196A1 EP1499196A1 EP03730381A EP03730381A EP1499196A1 EP 1499196 A1 EP1499196 A1 EP 1499196A1 EP 03730381 A EP03730381 A EP 03730381A EP 03730381 A EP03730381 A EP 03730381A EP 1499196 A1 EP1499196 A1 EP 1499196A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- flour
- baking industry
- products
- production
- bran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013312 flour Nutrition 0.000 title claims abstract description 108
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 52
- 235000008429 bread Nutrition 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 42
- 235000012970 cakes Nutrition 0.000 title claims abstract description 21
- 235000014594 pastries Nutrition 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 85
- 239000000654 additive Substances 0.000 claims abstract description 39
- 230000000996 additive effect Effects 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 17
- 241000209140 Triticum Species 0.000 claims abstract description 16
- 235000021307 Triticum Nutrition 0.000 claims abstract description 16
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims abstract description 13
- 108010068370 Glutens Proteins 0.000 claims abstract description 13
- 235000021312 gluten Nutrition 0.000 claims abstract description 13
- 239000003381 stabilizer Substances 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims description 17
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 239000000047 product Substances 0.000 description 92
- 150000001720 carbohydrates Chemical class 0.000 description 43
- 235000014633 carbohydrates Nutrition 0.000 description 43
- 235000010417 guar gum Nutrition 0.000 description 36
- 239000000665 guar gum Substances 0.000 description 35
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 229920002907 Guar gum Polymers 0.000 description 24
- 238000012360 testing method Methods 0.000 description 24
- 229960002154 guar gum Drugs 0.000 description 23
- 230000000694 effects Effects 0.000 description 16
- 235000005911 diet Nutrition 0.000 description 15
- 230000037213 diet Effects 0.000 description 15
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 14
- 239000003925 fat Substances 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000000835 fiber Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 235000021152 breakfast Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 230000000284 resting effect Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000015895 biscuits Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 244000303965 Cyamopsis psoralioides Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- UYXAWHWODHRRMR-UHFFFAOYSA-N hexobarbital Chemical compound O=C1N(C)C(=O)NC(=O)C1(C)C1=CCCCC1 UYXAWHWODHRRMR-UHFFFAOYSA-N 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 208000030159 metabolic disease Diseases 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 244000304337 Cuminum cyminum Species 0.000 description 3
- 235000007129 Cuminum cyminum Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- 108010064851 Plant Proteins Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 235000013310 margarine Nutrition 0.000 description 3
- 239000003264 margarine Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 235000021118 plant-derived protein Nutrition 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 206010027525 Microalbuminuria Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000021074 carbohydrate intake Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 235000020805 dietary restrictions Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- 235000008939 whole milk Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000020880 diabetic diet Nutrition 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
- A21D13/064—Products with modified nutritive value, e.g. with modified starch content with modified protein content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/183—Natural gums
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/265—Vegetable proteins from cereals, flour, bran
Definitions
- Bran-free, diabetic flours or flour mixtures for the production of baking industry products especially bread, pastries and cakes, furthermore, for the determination of the composition of flour mixtures, or flour and additive mixtures, and the production of suitable baking industry products using them.
- Type 2 diabetes a chronic metabolism disorder, which is characterised by hyperglycaemia caused by insulin secretion disorder.
- Type 2 diabetes primarily develops as a consequence of insulin resistance and can go hand in hand with numerous intercurrent diseases) high triglyceride level, low HDL cholesterol level, microalbuminuria, hypertension, pathological obesity, coagulation deviations, icshaemic heart disease). With the development of diabetes both micro and macrovascular complications can occur.
- the treatment of hyperglycaemia and/or high blood pressure reduces the frequency of occurrence of microangiopathia and the regulation of dyslipidaemia and/or high blood pressure also reduces the frequency of occurrence of macroangiopathia.
- the treatment of persons suffering from type 2 diabetes is usually carried out via dietary restrictions and the increase of physical activity.
- the diabetic flour mixture or flour described in Hungarian patent registration number HU 203 455 B entitled "Procedure for the production of low-calorie flour mixtures, or flour and baking industry products” contains wheat bran, semolina, gluten flour, as well as complex baking industry additive and preservative.
- the fibre content of the product comes from the wheat semolina and bran, which, however, damages the enjoyment value of the baking industry products produced. An attempt is made to counterbalance this effect with taste, aroma and other baking industry additives.
- the examples describe products containing flavouring materials containing soya flour, e.g. cumin, as well as preservative e.g. calcium sorbate, calcium propionate, all the products have a gritty or bran character and have hardly any enjoyment value.
- European patent registration number EP 0 656 748 describes "bread-like" products and the powder mixtures required for their production that reduce the blood sugar level and that can also be consumed by diabetics.
- the products contain at least 50 m% of wheat bran, so the amount of carbohydrate absorbed is significantly reduced, nut because of the high bran content the enjoyment value of the products is low.
- the authors of European patent registration number EP 0 005 977 describe bread containing guar gum and its preparation. They assume a required daily intake of 10-30 g of guar gum, which counts as therapy treatment.
- the bread contains 5-50% of carbo-hydroxide gum, guar gum, pectin and soluble, non-toxic alkylcellulose.
- wheat flour occasionally wheat gluten and corn flour is used.
- the invention is aimed at the production of long life bread that has a shelf life of about one year, the product is produced in a crispy, dry bread form. Baking is carried out in forms that are not closed with an airtight seal so that the steam that is created can escape. The form is cylindrical, so round products are produced, which following baking and removal from the forms are dried in a microwave oven.
- the dried bread is sliced and packaged. In order to get the desired amount of guar gum into the body they recommend the consumption of 16-25 slices of such bread.
- the enjoyment value of the dried bread according to the invention is lower than that of a fresh product, in the case of continuous consumption it becomes boring after a short period of time due to its dryness, it is unappetising and leads to the lack of appetite in the patient, which further damages the feeling of comfort.
- extruded bread is made for diabetics and those suffering from other glucose breakdown problems.
- the product contains 60 m% of plant fibres, and among them some of them are digestible, like, for example, maize, rice, sorghum, cassava, sesame fibre as whole ground flours, as well as other celluloses and hemicellulose. It may also contain fibre materials extracted from vegetable plants and natural pectins, carrot, spinach, turnip, wheat germ and unsaturated triglycerides derived from plant oils, salt and carrier materials, as well as natural gum. Using different processes biscuits, cakes and ball-shaped finished products are made from the mixture in a dried, extruded form.
- the product obtained is dry and solid with little enjoyment value.
- those fresh bakery products that can be included in the diet of diabetics and that have been in distribution up till now are based on being enriched primarily with wheat fibre and also, possibly, the fibre of other seeds (wheat, oats, soya, maize), so reducing the proportion of digestible carbohydrate.
- the task was solved by working out the composition of the daily consumed fresh bakery goods and the production process in such a way that that realisation of the baking industry process take place using the equipment usual in bakeries.
- bran-free diabetic flours or flour mixtures from which especially diabetic bread, pastries and cakes can be made that have appropriate enjoyment characteristics.
- composition of additive mixtures required for the production of bran-free, diabetic baking industry products, especially bread, pastries and cakes that on addition to usual baking industry products diabetic, baking industry products can be made that meet the expectations of them.
- bran-free diabetic flour or flour mixture for the production of baking industry products especially bread, pastries, cakes contains 30-80 m% wheat flour, 15-40 m% gluten flour, 2-10 m% guar flour and advantageously 5-15 m% rye flour, as well as known baking industry taste, aroma, state improver and other additives.
- the procedure for the production of bran-free diabetic baking industry product, especially bread, pastries and cakes is based on that the above flour mixture or flour, water and known leavening additive material when required are made into products using known baking industry procedures.
- the bran-free diabetic flour or flour mixture for the production of baking industry products, especially bread, pastries, cakes contains the necessary additive material, 20-60 m% gluten flour, 4-30 m% guar flour and advantageously 5-25 m% rye flour, as well as known baking industry taste, aroma, stabiliser and other additives as required.
- the procedure for the production of bran-free diabetic baking industry product, especially bread, pastries and cakes is based on that the above additive mixture is added to usual baking industry basic materials, and the finished product is made using known baking industry procedures.
- the baking industry procedures carried out from the flour mixture or flour according to the invention or from known baking industry basic materials with the additive mixture according to the invention can be realised in usual baking industry equipment with the known processes.
- a fast mixing machine with a speed of at least 240 rpm in order to counterbalance the strong gluten structure and the exceptional tough effect of guar gum.
- Baking should take place in a temperature-regulated oven containing saturated steam, for 2 minutes at an initial temperature of between 265-290° C, advantageously between 270-280° C, then for 15-60 minutes, advantageously between 25-50 minutes at a baking temperature of between 210-240° C, advantageously between 210-225° C.
- the recommended lower values are optimal for pastries and the upper values relate to bread.
- the cooling of the finished product should be longer than is usual, 1-2.5 hours.
- polypropylene film bags for example, for the packaging material that are perforated on one side, which is suitable for maintaining the appropriate humidity balance.
- the presented diabetic bread can be sliced using the usual vibrating knife slicer, it is practical to package slices with a thickness between 9-16 mm.
- the execution of the procedure according to the invention may take place in such a way that when mixing the dough place all of the ingredients into the mixing bowl at the same time, including the prescribe amount of water as well, the kneaded dough should be rested for a maximum of 5 minutes, raising or leavening should take place in a raising chamber with a relative humidity of 75-100%, for between 30- 40 minutes, at a temperature of between 34-40° C.
- baking should take place in a temperature-regulated oven containing saturated steam, for 2 minutes at an initial temperature of between 265-290° C, advantageously between 270- 280° C, then for 15-60 minutes, advantageously between 25-50 minutes at a baking temperature of between 210-240° C, advantageously between 210-225° C, the cooling of the finished product should take between 1-2.5 hours and distribution should take place in packaging.
- the shelf life of the flours or flour mixtures and additive mixture presented is 1 year, they are baking industry materials that keep well.
- the products can be used to advantage for the diets of diabetics, they have good enjoyment value and supplement therapy effectively.
- the price of the goods is not exaggerated, about 50% higher than normal baking industry products, this, however, is counterbalanced by the advantages and by that using them in the diet of some patients the degree of pharmaceutical treatment can be reduced or avoided altogether.
- the developed products also fill an important role in healthy eating, they prevent obesity, including the later consequences of this, for example, high blood pressure and vascular illnesses.
- similar macroeconomic advantages can be forecast, because consumption of the product has an effect against the increasing amount of obesity in the population. It is well known that obese people have a much higher tendency to develop various heart and vascular diseases and diabetes.
- the primary area of application of the product according to the invention is the diets of diabetics.
- a balance has to be maintained between the amount of carbohydrate consumed and the changes in the patient's blood sugar level related to the patient's condition.
- the feel of comfort in other words how the patient treats the diet, whether the patient treats it as fasting, whether the patient is able to get that full up feeling, whether he/she consumes the bakery goods necessary for him/her with a good appetite.
- the baking industry products prepared from the flour mixtures and additive mixture according to the invention provide assistance with this complex problem.
- Diabetics consume the amount of carbohydrates they can have with bakery products in the form of buns, because the amount of carbohydrate intake can be clearly determined and tracked.
- the carbohydrate content of 1 normal bun is 30 g.
- the carbohydrate content of a bun made according to the invention is 20 g. Only taking this into account the of the total daily carbohydrate consumption the daily consumption of diabetic buns is 3-7.5 buns. This in itself already makes possible significant extra food intake.
- the essence of our invention is that besides the plant protein intake replacing the carbohydrate content a part of the remaining, carbohydrate is difficult to absorb and the absorption inhibitor is replaced by a natural plant ingredient. This ingredient is guar flour.
- Type 2 diabetes is a chronic metabolism disorder, which is characterised by hyperglycaemia caused by insulin effect/secretion disorder (3).
- Type 2 diabetes primarily develops as a consequence of insulin resistance and can go hand in hand with numerous intercurrent diseases) high triglyce de level, low HDL cholesterol level, microalbuminuria, hypertension, pathological obesity, coagulation deviations, icshaemic heart disease [6]).
- hyperglycaemia and/or high blood pressure reduces the frequency of occurrence of microangiopathia and the regulation of dyslipidaemia and/or high blood pressure also reduces the frequency of occurrence of macroangiopathia (7).
- the treatment of persons suffering from type 2 diabetes is usually carried out via dietary restrictions and the increase of physical activity.
- This additive material is guar gum (E412), which is known in the food industry as a binding agent, which is a polysaccharide with a large molecular mass, a so-called resistant polysaccharide. It is resistant to the majority of digestive enzymes. It is a natural material, a cellulose-type polysaccharide from the powdered endosperm of the seed of the guar plant, Cyamopsis tetragonoloba, belonging to the pulses. It belongs to the Leguminosae family. The plant itself originates from India and Pakistan.
- guaran which consists of linear chains of (1-4)- fl-D-mannopyranosyl units with -D-galactopyranosay units attached by (1-6) linkages.
- Matzkies et al showed that a daily intake of 12 g of guar flour can realise in significant blood sugar level improvement (5).
- Gatenby et al experienced significant blood sugar level reduction in type 2 diabetics following the consumption of a breakfast containing 7.6 g guar gum (E412) and 75 g carbohydrate as compared to the control (4).
- guar gum E421 counts for approximately 10% of the total carbohydrate content. By using it the patient can not only consume more food due to the 30% carbohydrate reduction, but also because as a result of the guar gum (E 421) the blood sugar fluctuation following a meal is reduced. The moderation of postprandial hyperglycaemia also reduces the risk of the development of vascular complications developing in type 2 diabetics.
- the aim of our test was to prove that following the consumption of a test breakfast containing 45 g carbohydrate and 4.5 g guar gum (E412) a significant blood sugar level reduction can be experienced as compared to the blood sugar level increasing effect of a control breakfast - not containing guar gum (E421) - containing the same amount of carbohydrate.
- the test involved 9 type 2 diabetic patients - not requiring insulin treatment - (age: 57.2 ⁇ 3.3 years, duration of illness: 10.1+3.4 years, BMI: 28.8 ⁇ 0.9 kg/m 2 , RR: 136.7+4.1/66.7+1.7 Hgmm, HbA, c : 7.7 ⁇ 0.4, average ⁇ SE). Before the patients were involved in the test detailed laboratory tests were carried out. If a patient conformed to the inclusion criteria we informed him/her of the details of the test, then after signing the approval declaration we included the patient in the test. The test took 2 days: on the first day the control bun was eaten, then on the second day the test bun was consumed. The control material was a bun of normal composition (30 g carbohydrate content each).
- the blood sugar level measurement of the patients took place before eating (fasting value), then at 30, 60, 90, 120 and 180 minutes following consumption of the breakfast.
- the biometric analysis of our data was carried out using one aspect distribution analysis. We viewed the p value as significant if its value was lower than 0.05.
- the patients were examined in accordance with the test protocol for 2 days. In the case of hypoglycaemia occurring we were able to suspend the test immediately, however, this did not take place.
- the patients were able to report to the Diabetes Outpatients department at the clinic at any time in the case of any side effects or to the doctors carrying out the test at our clinic (Dr Csaba Lengyel and Dr Tamas Varkonyi).
- the measured blood sugar values given during the test are shown in a simple table- diagram.
- the diagram (Fig.1.) shows the change of the POSTPRANDIAL SUGAR LEVEL on the effect of guar gum (E 412).
- reaven GM Insulin resistance and its consequences: non-insulin dependent diabetes mellitus and coronary heart disease.
- UK Prospective Diabetes Study Group (UKPDS 38): Tight blood glucose control and risk of macrovascular and microvascular complications in type 2 diabetes Br Med J 1998, 317; 703-713.
- the secondary area of application of the products according to the invention due to the reduction of absorption, may be in slimming diets.
- the guar flour taken in with the bun acts as dietary fibre, it promotes the operation of the intestines, reducing transit time, and due to its strong absorption ability it is suitable for binding certain food constituents (fats, simple carbohydrates) and damaging free radicals. Due to this is has an exceptionally good effect on the nutrition of our civilisation, which is exceptionally low in fibre intake.
- the products have a slimming effect if we consume them in the same way as we would normal baking industry products for breakfast, lunch and dinner, in the form of buns, rolls and bread. If you do not pay any special attention to the amount consumed, and you consume them beside other normal foods, even then they have a favourable effect. From the point of view of sugar metabolism in the case of a healthy person it does not happen that as a consequence of the consumption of the product the blood sugar level drops below the optimum, as this is regulated by natural insulin production.
- Example 1 Additive mixture for the production of buns and rolls
- composition characteristics of the received additive mixture of 100 g of product are identical to the composition characteristics of the received additive mixture of 100 g of product:
- composition characteristics of the received additive mixture of 100 g of product are identical to the composition characteristics of the received additive mixture of 100 g of product:
- Example 3 Flour mixture for direct baking industry use
- composition characteristics of the received flour mixture of 100 g of product The composition characteristics of the received flour mixture of 100 g of product:
- composition characteristics of the received diabetic flour mixture of 100 g of product are identical to the composition characteristics of the received diabetic flour mixture of 100 g of product:
- Example 5 The production of buns with additive mixture
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 2 minutes, then quickly for 6 minutes.
- the temperature of the dough 26-28° C.
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into balls manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 20-30 minutes.
- the product was baked for 2 minutes at between 270-280° C, then for 20 minutes at between 210-215° C. From the above amounts we made 100 diabetic buns.
- Example 6 The production of rolls with additive mixture
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 2 minutes, then quickly for 6 minutes.
- the temperature of the dough 26-28° C.
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into rolls manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 30-40 minutes, they were decorated with a mixture of salt and cumin seeds.
- the product was baked for 2 minutes at between 270-280° C, then for 23 minutes at between 220-225° C. From the above amounts we made 100 diabetic rolls.
- Example 7 The production of buns from flour mixture
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 2 minutes, then quickly for 6 minutes.
- the temperature of the dough was
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into buns manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 20-30 minutes.
- the product was baked for 2 minutes at between 270-280° C, then for 20 minutes at between 210-215° C. From the above amounts we made 100 diabetic buns.
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 2 minutes, then quickly for 6 minutes.
- the temperature of the dough was
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into rolls manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 30-40 minutes, they were decorated with a mixture of salt and cumin seeds.
- the product was baked for 2 minutes at between 270-280° C, then for 23 minutes at between 220-225° C. From the above amounts we made 100 diabetic rolls.
- Example 9 The production of bread with additive mixture
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 1 minute, then quickly for 4 minutes.
- the temperature of the dough 26-28° C.
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into loaves manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 30-40 minutes.
- the product was baked for 5 minutes at between 270-280° C, then for 45 minutes at between 210-215° C. From the above amounts we made 116 0.5 kg diabetic loaves of bread.
- the composition characteristics of the bread made in this way per 100 g: Energy content: 936 kJ Protein: 16.8 g Carbohydrate: 37.2 g Fat: 0.8 g
- Example 10 The production of bread from flour mixture
- the components were mixed into a dough using the total amount of water in a fast mixing machine first slowly for 1 minute, then quickly for 4 minutes.
- the temperature of the dough :
- the resting time for the dough 5 minutes.
- the dough was divided in a dividing machine and made into loaves manually, then left to rise in a temperature of 34-36° C in a relative humidity of 75-80% for 30-40 minutes.
- the product was baked for 5 minutes at between 270-280° C, then for 45 minutes at between 210-215° C. From the above amounts we made 116 0.5 kg diabetic loaves of bread.
- composition characteristics of the bread made in this way per 100 g are identical to each other.
- Example 11 The production of diabetic biscuits
- the powder materials were mixed and a homogenous dough was made, then made into forms and baked.
- Example 12 Diabetic sweet and savoury shortcrust biscuits
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0201270A HU226088B1 (en) | 2002-04-18 | 2002-04-18 | Diabetic flour, flourmix and admixture free from bran and process for producing of baking product especially bread, rolls and cake and using these |
HU0201270 | 2002-04-18 | ||
PCT/HU2003/000028 WO2003086083A1 (en) | 2002-04-18 | 2003-04-15 | Diabetic, bran-free flour for the production of backing industry products, especially bread, pastries and cakes |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1499196A1 true EP1499196A1 (en) | 2005-01-26 |
Family
ID=89980369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03730381A Withdrawn EP1499196A1 (en) | 2002-04-18 | 2003-04-15 | Diabetic, bran-free flour for the production of baking industry products, especially bread, pastries and cakes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1499196A1 (hu) |
AU (1) | AU2003241061A1 (hu) |
HU (1) | HU226088B1 (hu) |
WO (1) | WO2003086083A1 (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0501123A2 (en) * | 2005-11-29 | 2007-08-28 | Diabet Trade Kft | Diabetic flour made from higher and whole grinding cereal or flour mix or ad mixture mix |
JP4512558B2 (ja) | 2006-02-15 | 2010-07-28 | 株式会社神戸屋 | パンの製造方法 |
EP2179661A1 (en) * | 2008-10-23 | 2010-04-28 | Generale Biscuit | Biscuit comprising guar gum in a rod-like form |
FR3024940B1 (fr) * | 2014-08-25 | 2017-11-10 | Fandy Maroc Farine | Composition alimentaire apte a se substituer au moins partiellement a la farine |
CN111919997A (zh) * | 2020-09-01 | 2020-11-13 | 赵子超 | 一种欧防风面粉(ⅱ)及其制作工艺 |
CN111972605A (zh) * | 2020-09-01 | 2020-11-24 | 赵子超 | 一种欧防风面粉及其制作工艺 |
CN111972606A (zh) * | 2020-09-01 | 2020-11-24 | 赵子超 | 一种欧防风面粉及其制作工艺 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0005977A3 (en) * | 1978-05-30 | 1980-01-09 | The Speywood Laboratory Ltd. | Bread containing gum and its manufacture |
-
2002
- 2002-04-18 HU HU0201270A patent/HU226088B1/hu not_active IP Right Cessation
-
2003
- 2003-04-15 WO PCT/HU2003/000028 patent/WO2003086083A1/en not_active Application Discontinuation
- 2003-04-15 AU AU2003241061A patent/AU2003241061A1/en not_active Abandoned
- 2003-04-15 EP EP03730381A patent/EP1499196A1/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO03086083A1 * |
Also Published As
Publication number | Publication date |
---|---|
HU0201270D0 (hu) | 2002-06-29 |
HU226088B1 (en) | 2008-04-28 |
AU2003241061A1 (en) | 2003-10-27 |
AU2003241061A8 (en) | 2003-10-27 |
HUP0201270A2 (hu) | 2004-05-28 |
WO2003086083A1 (en) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ho et al. | Physico-chemical characteristics and sensory evaluation of wheat bread partially substituted with banana (Musa acuminata X balbisiana cv. Awak) pseudo-stem flour | |
Mohebbi et al. | Effects of beta-glucan and resistant starch on wheat dough and prebiotic bread properties | |
Juarez-Garcia et al. | Composition, digestibility and application in breadmaking of banana flour | |
US6984407B2 (en) | High satiety index bread | |
EP1744772B1 (en) | Flaxseeds for body weight management | |
WO2012076911A2 (en) | Low carbohydrate flours for the food industry and use thereof in semi-finished and final food products | |
US6413562B2 (en) | Healthy bread crumbs | |
JP2006527996A (ja) | テフ粉末の加工法 | |
CN110612027A (zh) | 烘焙食品用混合料 | |
CN111011431A (zh) | 适用于糖尿病人群的苏打饼干及其制备方法 | |
US5384136A (en) | Psyllium-enriched dough products and method for making the same | |
Urooj et al. | Effect of barley incorporation in bread on its quality and glycemic responses in diabetics | |
WO2007063349A1 (en) | Diabetic finished flours or flour mixtures or additive mixtures made from mostly whole-grain and whole-grain cereals | |
WO2003086083A1 (en) | Diabetic, bran-free flour for the production of backing industry products, especially bread, pastries and cakes | |
Bartkiene et al. | Psyllium husk gel used as an alternative and more sustainable scalding technology for wheat bread quality improvement and acrylamide reduction | |
Janda et al. | The role of oat products in the prevention and therapy of type 2 diabetes, hypercholesterolemia and obesity | |
WO2007056802A1 (en) | Low gi white bread product | |
CN109197954A (zh) | 一种南瓜味杂粮苏打饼干及其制备方法 | |
JP6862295B2 (ja) | 惣菜パン類の製造方法 | |
Kanaujiya et al. | To nutritional profile of dietary fibre pizza base and sensory evaluation of develop product | |
KR100488470B1 (ko) | 뽕잎분말을 함유하는 호떡 반죽물 및 그에 내재되는 혼합물 | |
Gómez et al. | Effect of fibre in enriched breads | |
US20080199566A1 (en) | Fermented food and its preparation | |
RU2500108C1 (ru) | Пищевая композиция для производства хрустящих пшеничных хлебцев | |
CN115191460B (zh) | 一种紫色马铃薯苦荞半发酵饼干及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041117 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1075581 Country of ref document: HK |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DIABET TRADE KFT Owner name: GABONATERMESZTESI KUTATO KOEZHASZNU TARSASAG |
|
17Q | First examination report despatched |
Effective date: 20060720 |
|
17Q | First examination report despatched |
Effective date: 20060720 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1075581 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20111101 |